Scientists call it “the valley of death”.

Pharmaceutical and medical research tends to follow a well-worn path in the US: In its early stages, research is funded by the government and nonprofits, and conducted at universities and research institutes. At the end of its life cycle, when the outline of a promising drug or treatment takes shape, venture capitalists and drug companies show up with checkbooks.